Advertisement

AIDS and Behavior

, Volume 22, Issue 5, pp 1423–1429 | Cite as

A Cross-Sectional Study of Depressive Symptoms and Risky Alcohol Use Behaviors Among HIV Primary Care Patients in New York City

  • Yasemin Algur
  • Jennifer C. Elliott
  • Efrat Aharonovich
  • Deborah S. Hasin
Original Paper

Abstract

An association between problem drinking and depression among HIV-infected individuals has been previously demonstrated; however, which specific risky drinking behaviors are associated with higher levels of depression has not yet been investigated. Using an adult sample of HIV-infected primary care patients (78% male, 94% Black or Hispanic), we investigated whether depressive symptoms are associated with various risky drinking behaviors. Participants were administered the Beck Depression Inventory-II to assess depressive symptoms, and the Alcohol Use Disorders and Associated Disabilities Interview Schedule-IV to evaluate alcohol involvement. Participants with depressive symptoms (26%) were at higher risk for alcohol dependence [adjusted odds ratio (AOR) 3.8; 95% CI 2.0–7.2], regular binge drinking (AOR 2.0; 95% CI 1.1–3.8), and regular daytime drinking (AOR 2.1; 95% CI 1.2–3.8), in comparison with their non-depressed counterparts. Because both depression and unhealthy drinking negatively affect medication adherence and clinical outcomes, a better understanding of the association between depression and certain risky drinking behaviors among HIV-infected individuals is vital to improving their care and prognoses.

Keywords

Alcohol dependence Binge drinking Daytime drinking Depressive symptoms HIV 

Notes

Acknowledgements

We thank Derek Maloney, MD, and Erin Delker, MPH for their editorial and statistical guidance.

Funding

This work was supported by the National Institutes of Health (NIH) (Grant Nos. R01AA023163, R01AA014323, R01DA020647, K23AA023753) and the New York State Psychiatric Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Petry NM. Alcohol use in HIV patients: what we don’t know may hurt us. Int J STD AIDS. 1999;10(9):561–70.CrossRefPubMedGoogle Scholar
  2. 2.
    Dew MA, Becker JT, Sanchez J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med. 1997;27(2):395–409.CrossRefPubMedGoogle Scholar
  3. 3.
    Cook RL, Sereika SM, Hunt SC, Woodward WC, Erlen JA, Conigliaro J. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16(2):83–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Williams JB, Rabkin JG, Remien RH, Gorman JM, Ehrhardt AA. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry. 1991;48(2):124–30.CrossRefPubMedGoogle Scholar
  5. 5.
    Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retrovir. 2004;20(2):151–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV cost and services utilization study. J Stud Alcohol. 2002;63(2):179–86.CrossRefPubMedGoogle Scholar
  7. 7.
    Burnam MA, Bing EG, Morton SC, et al. Use of mental health and substance abuse treatment services among adults with HIV in the United States. Arch Gen Psychiatry. 2001;58(8):729–36.CrossRefPubMedGoogle Scholar
  8. 8.
    Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573–80.CrossRefPubMedGoogle Scholar
  9. 9.
    Samet JH, Horton NJ, Meli S, Freedberg KA, Palepu A. Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcohol Clin Exp Res. 2004;28(4):572–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Bazargan-Hejazi S, Bazargan M, Hardin E, Bing EG. Alcohol use and adherence to prescribed therapy among under-served Latino and African-American patients using emergency department services. Ethn Dis. 2005;15(2):267–75.PubMedGoogle Scholar
  11. 11.
    Walkup J, Wei W, Sambamoorthi U, Crystal S. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q. 2008;79(1):43–53.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Parsons JT, Starks TJ, Millar BM, Boonrai K, Marcotte D. Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence. Drug Alcohol Depend. 2014;139:33–40.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. J Acquir Immune Defic Syndr. 2007;46(2):194–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J. Causal considerations on alcohol and HIV/AIDS—a systematic review. Alcohol Alcohol. 2010;45(2):159–66.CrossRefPubMedGoogle Scholar
  16. 16.
    Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(8):807–16.CrossRefPubMedGoogle Scholar
  17. 17.
    Hasin DS, Goodwin RD, Stinson FS, Grant BF. Epidemiology of major depressive disorder: results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatry. 2005;62(10):1097–106.CrossRefPubMedGoogle Scholar
  18. 18.
    Stall R, McKusick L, Wiley J, Coates TJ, Ostrow DG. Alcohol and drug use during sexual activity and compliance with safe sex guidelines for AIDS: the AIDS behavioral research project. Health Educ Q. 1986;13(4):359–71.CrossRefPubMedGoogle Scholar
  19. 19.
    Theall KP, Clark RA, Powell A, Smith H, Kissinger P. Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS Behav. 2007;11(2):205–15.CrossRefPubMedGoogle Scholar
  20. 20.
    Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey. Arch Gen Psychiatry. 1994;51(1):8–19.CrossRefPubMedGoogle Scholar
  21. 21.
    Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158(5):725–30.CrossRefPubMedGoogle Scholar
  22. 22.
    Komiti A, Judd F, Grech P, et al. Depression in people living with HIV/AIDS attending primary care and outpatient clinics. Aust N Z J Psychiatry. 2003;37(1):70–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Horberg MA, Silverberg MJ, Hurley LB, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47(3):384–90.CrossRefPubMedGoogle Scholar
  24. 24.
    Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S136–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Cook JA, Cohen MH, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30(4):401–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Cruess DG, Petitto JM, Leserman J, et al. Depression and HIV infection: impact on immune function and disease progression. CNS Spectr. 2003;8(1):52–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159(10):1752–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Cook JA, Grey D, Burke J, et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. Am J Public Health. 2004;94(7):1133–40.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Sullivan LE, Saitz R, Cheng DM, Libman H, Nunes D, Samet JH. The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients. Addiction. 2008;103(9):1461–7.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Bryant VE, Whitehead NE, Burrell LE 2nd, et al. Depression and apathy among people living with HIV: implications for treatment of HIV associated neurocognitive disorders. AIDS Behav. 2015;19(8):1430–7.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Esser MB, Hedden SL, Kanny D, Brewer RD, Gfroerer JC, Naimi TS. Prevalence of alcohol dependence among US adult drinkers, 2009–2011. Prev Chronic Dis. 2014;11:E206.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis. 2014;11:E109.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Wen XJ, Balluz L, Town M. Prevalence of HIV risk behaviors between binge drinkers and non-binge drinkers aged 18- to 64-years in US, 2008. J Community Health. 2012;37(1):72–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Durham MD, Hart R, Buchacz K, et al. Antiretroviral nonadherence and condomless sex in the HIV outpatient study, USA, 2007–2014. Int J STD AIDS. 2017;.  https://doi.org/10.1177/0956462417720547.PubMedGoogle Scholar
  35. 35.
    Smart RG, Adlaf EM, Knoke D. Use of the CAGE scale in a population survey of drinking. J Stud Alcohol. 1991;52(6):593–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Hasin DS, Aharonovich E, O’Leary A, et al. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction. 2013;108(7):1230–40.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders, research version, non-patient edition (SCID-I/NP). New York: Biometrics Research, New York State Psychiatric Institute; 2002.Google Scholar
  38. 38.
    Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1996.Google Scholar
  39. 39.
    Reitan R, Wolfson D. The Halstead–Reitan neuropsychological test battery: theory and clinical interpretation. 2nd ed. Tucson: Neuropsychology Press; 1992.Google Scholar
  40. 40.
    Brantley PJ, Dutton GR, Wood KB. The Beck Depression Inventory—II (BDI–II) and the Beck Depression Inventory—primary care (BDI–PC). In: Maruish ME, editor. The use of psychological testing for treatment planning and assessment outcome. 3rd ed. Mahwah: Erlbaum; 2004. p. 313–26.Google Scholar
  41. 41.
    Hobkirk AL, Starosta AJ, De Leo JA, et al. Psychometric validation of the BDI-II among HIV-positive CHARTER study participants. Psychol Assess. 2015;27(2):457–66.CrossRefPubMedGoogle Scholar
  42. 42.
    Dozois DJA, Covin R. The Beck Depression Inventory-II, beck hopelessness scale, and beck scale for suicide ideation. In: Hersen M, Segal DL, Hilsenroth M, editors. Comprehensive handbook of psychological assessment, personality assessment, vol. 2. Hoboken: Wiley; 2004.Google Scholar
  43. 43.
    Wiebe JS, Penley JA. A psychometric comparison of the Beck Depression Inventory-II in English and Spanish. Psychol Assess. 2005;17(4):481–5.CrossRefPubMedGoogle Scholar
  44. 44.
    Steer RA, Ball R, Ranieri WF, Beck AT. Further evidence for the construct validity of the Beck Depression Inventory-II with psychiatric outpatients. Psychol Rep. 1997;80(2):443–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Arbisi PA. Review of the Beck Depression Inventory-II. In: Plake BS, Impara JC, editors. The fourteenth mental measurements yearbook. Lincoln: Buros Institute of Mental Measurements; 2001.Google Scholar
  46. 46.
    Grothe KB, Dutton GR, Jones GN, Bodenlos J, Ancona M, Brantley PJ. Validation of the Beck Depression Inventory-II in a low-income African American sample of medical outpatients. Psychol Assess. 2005;17(1):110–4.CrossRefPubMedGoogle Scholar
  47. 47.
    Penley JA, Wiebe JS, Nwosu A. Psychometric properties of the Spanish Beck Depression Inventory-II in a medical sample. Psychol Assess. 2003;15(4):569–77.CrossRefPubMedGoogle Scholar
  48. 48.
    Grant BF, Dawson DA, Hasin DS. The Alcohol use disorder and associated disabilities interview schedule-DSM-IV version. Bethesda: National Institute on Alcohol Abuse and Alcoholism; 2001.Google Scholar
  49. 49.
    National Institute on Alcohol Abuse and Alcoholism. Drinking levels defined. https://www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/moderate-binge-drinking.
  50. 50.
    Cottler LB, Grant BF, Blaine J, et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug Alcohol Depend. 1997;47(3):195–205.CrossRefPubMedGoogle Scholar
  51. 51.
    Hasin D, Carpenter KM, McCloud S, Smith M, Grant BF. The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug Alcohol Depend. 1997;44(2–3):133–41.CrossRefPubMedGoogle Scholar
  52. 52.
    Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP. The Alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39(1):37–44.CrossRefPubMedGoogle Scholar
  53. 53.
    Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71(1):7–16.CrossRefPubMedGoogle Scholar
  54. 54.
    Canino G, Bravo M, Ramirez R, et al. The Spanish alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. J Stud Alcohol. 1999;60(6):790–9.CrossRefPubMedGoogle Scholar
  55. 55.
    SAS Institute Inc. SAS/STAT® software, Version 9.3. 2011.Google Scholar
  56. 56.
    Sullivan LE, Goulet JL, Justice AC, Fiellin DA. Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection. Drug Alcohol Depend. 2011;117(2–3):158–63.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2017

Authors and Affiliations

  • Yasemin Algur
    • 1
    • 2
  • Jennifer C. Elliott
    • 1
    • 3
  • Efrat Aharonovich
    • 1
    • 3
  • Deborah S. Hasin
    • 1
    • 2
    • 3
  1. 1.New York State Psychiatric InstituteNew YorkUSA
  2. 2.Department of Epidemiology, Mailman School of Public HealthColumbia UniversityNew YorkUSA
  3. 3.Department of PsychiatryColumbia University Medical CenterNew YorkUSA

Personalised recommendations